Company intelligence / Profile preview

IBA Lifesciences

Göttingen, Niedersachsen, Germanyibanet.org ↗

Ownership: Private
Development stage: Other

Overview

IBA Lifesciences was a leading German biotechnology company specializing in high-performance research tools for protein purification and cell selection, most notably the Strep-tag®/Strep-Tactin® affinity chromatography system. Its products are widely used in academic and industrial life science research worldwide. In January 2025, the company was acquired by Cube Biotech to form a unified entity focused on advancing solutions in protein purification, stabilization, and challenging drug targets[5][9].

Modalities: ProteinRecombinant proteinCustom oligonucleotide (DNA & RNA)
Industry: Non-Drug Biotech

Partnerships

Distributors in over 40 countries including Nacalai, Cosmo Bio, Funakoshi (Japan)collaborations with Max Planck Society (technology originator)

Beyond the preview

Go deeper on IBA Lifesciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on IBA Lifesciences.

Explore the full profile